Drug-Loaded Polymeric Micelles Based on Smart Biocompatible Graft Copolymers with Potential Applications for the Treatment of Glaucoma

• Published in: International journal of molecular sciences 2022-08, Vol.23 (16), p.9382
• Main Authors: Ozturk, Manuela-Ramona Blanaru, Popa, Marcel, Rata, Delia Mihaela, Cadinoiu, Anca Niculina, Parfait, Frederique, Delaite, Christelle, Atanase, Leonard Ionut, Solcan, Carmen, Daraba, Oana Maria
• Format: Article
• Language: English
• Subjects: Animals; Bioavailability; Biocompatibility; Biomedical materials; Block copolymers; Copolymers; Core-shell particles; cytotoxicity; Degree of polymerization; Dialysis; dorzolamide; Drug Carriers; Drug delivery; Drug delivery systems; Drugs; Efficiency; Encapsulation; Eye diseases; Glaucoma; Glaucoma - drug therapy; Graft copolymers; Health services; Hemodialysis; Immunosuppressive agents; In vivo methods and tests; Indomethacin; Inflammation; Intraocular pressure; Light scattering; Micelles; Molecular weight; Nanoparticles; Photon correlation spectroscopy; Polycaprolactone; Polyesters; Polyethylene Glycols; polymeric micelles; Polymers; Renal Dialysis; Self-assembly
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23169382

Glaucoma is the second leading cause of blindness in the world. Despite the fact that many treatments are currently available for eye diseases, the key issue that arises is the administration of drugs for long periods of time and the increased risk of inflammation, but also the high cost of eye surgery. Consequently, numerous daily administrations are required, which reduce patient compliance, and even in these conditions, the treatment of eye disease is too ineffective. Micellar polymers are core-shell nanoparticles formed by the self-assembly of block or graft copolymers in selective solvents. In the present study, polymeric micelles (PMs) were obtained by dialysis from smart biocompatible poly(ε-caprolactone)-poly(N-vinylcaprolactam-co-N-vinylpyrrolidone) [PCL-g-P(NVCL-co-NVP)] graft copolymers. Two copolymers with different molar masses were studied, and a good correlation was noted between the micellar sizes and the total degree of polymerisation (DPn) of the copolymers. The micelles formed by Cop A [PCL120-g-P(NVCL507-co-NVP128)], with the lowest total DPn, have a Z-average value of 39 nm, whereas the micellar sizes for Cop B [PCL120-g-P(NVCL1253-co-NVP139)] are around 47 nm. These PMs were further used for the encapsulation of two drugs with applications for the treatment of eye diseases. After the encapsulation of Dorzolamide, a slight increase in micellar sizes was noted, whereas the encapsulation of Indomethacin led to a decrease in these sizes. Using dynamic light scattering, it was proved that both free and drug-loaded PMs are stable for 30 days of storage at 4 °C. Moreover, in vitro biological tests demonstrated that the obtained PMs are both haemo- and cytocompatible and thus can be used for further in vivo tests. The designed micellar system proved its ability to release the encapsulated drugs in vitro, and the results obtained were validated by in vivo tests carried out on experimental animals, which proved its high effectiveness in reducing intraocular pressure.